Table 4A.
Cytopoenic tendency in the study population
| HIV Patients | Male Patients | |||||
| Parameters | HAART | On | OR | HAART | On | OR |
| Naïve | HAART | (95% CI) | Naïve | HAART | (95%CI) | |
| TWBC (< 2.5 k/µL) | 18(7.7) | 9(6.0) | 1.3(0.6–3.0) | 4(6.2) | 1(3.1) | 2.0(0.2–19.0) |
| LYM (< 40%) | 39(16.7) | 8(5.3) *** | 3.6(1.6–7.9) | 13(20.0) | 4(12.5) | 1.8(0.5–5.9) |
| Neut (< 60%) | 225(96.2) | 150(99.3) | 0.2(0.02–1.3) | 61(93.9) | 31(96.9) | 0.5(0.05–4.59) |
| TLC (< 1.2 k/µL) | 16(6.8) | 6(4.0) | 1.8(0.8–4.6) | 6(9.2) | 3(9.4) | 0.9(0.2–4.2) |
| PCV (< 30%) | 88(37.6) | 23(15.2)*** | 3.4(2.0–5.6) | 18(27.7) | 4(12.5) | 2.7(0.8–8.7) |
| PLT (< 150 k/µL) | 118(50.4) | 78(51.7) | 1.0(0.6–1.4) | 32(49.2) | 13(40.6) | 1.4(0.6–3.3) |
*P ≤ 0.05, ***P ≤ 0.001 indicates the level of significance when HAART-naïve were compared to those on HAART (unpaired t-test); TWBC = Total white blood cell count; LYM = Lymphocyte; Neut = Neutrophil; TLC = Total lymphocyte count; PCV = Packed cell volume; PLT = Platelet.